Trexquant Investment LP Assembly Biosciences, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.33 - $6.63 $67,890 - $103,951	-15,679 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$4.87 - $17.29 $76,356 - $271,089	15,679 New	15,679 $95,000
Q2 2018 Aug 07, 2018	SELL	$39.21 - $50.29 $225,379 - $289,066	-5,748 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$41.7 - $64.16 $33,651 - $51,777	807 Added 16.33%	5,748 $282,000
Q4 2017 Feb 09, 2018	BUY	$28.58 - $49.91 $141,213 - $246,605	4,941	4,941 $224,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.